Raised inflammatory markers may indicate poorer quality of life in advanced cancerBMJ 2016; 353 doi: https://doi.org/10.1136/bmj.i3582 (Published 28 June 2016) Cite this as: BMJ 2016;353:i3582
- Ingrid Torjesen
Controlling the immune system in people with terminal cancer may help improve their quality of life, a study published in the Journal of Clinical Oncology shows.1
A team at the University of Edinburgh assessed inflammation levels in 2520 cancer patients across Europe and found that the level of inflammation had a direct effect on how they felt in terms of pain, fatigue, loss of …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial